Mustang Bio, Inc.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US62818Q2030
USD
0.77
-0.05 (-5.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Mustang Bio, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-1.00
-15.00
-51.00
-77.00
-66.00
-60.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-1.00
0.00
-2.00
4.00
0.00
3.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-5.00
-11.00
-49.00
-65.00
-53.00
-37.00
Cash Flow from Investing Activities
1.00
0.00
5.00
-2.00
-5.00
-4.00
Cash Flow from Financing Activities
14.00
11.00
-26.00
34.00
70.00
78.00
Net Cash Inflow / Outflow
10.00
0.00
-69.00
-33.00
11.00
36.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mustang Bio, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-1.921
-9.627305
8.00
80.05%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-1.683
-0.243557
-1.00
-591.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-5.264
-9.760721
4.00
46.07%
Cash Flow from Investing Activities
1.165
5.891085
-4.00
-80.22%
Cash Flow from Financing Activities
14.526
2.869552
12.00
406.21%
Net Cash Inflow / Outflow
10.427
-1.000084
11.00
1142.61%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 53.87% vs 76.94% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-5.26
-11.41
53.87%